Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 30-04 (MA.27) 

A randomized phase III trial of exemestane vs. anastrozole in postmenopausal women with receptor positive primary breast cancer

DESIGN

Please click on the picture to see a larger version

Results & Publications


Presentations


Publications

Study Chairs
IBCSG: Dr. Manuela Rabaglio - Bern, Switzerland
NCIC CTG: Dr. Paul Goss - Boston, USA

Lead Trial Coordinator
Holly Shaw

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg30_MA27@fstrf.org


Date of Activation
April 12, 2005

Date of Closure
December 15, 2006

Targeted Accrual
6840 patients

Final Accrual
7576 patients


Results Publications Results & Publications
Other Pathology


News

23.09.2016:
BIG Time for Baby - the Storks spread their wings

20.09.2016:
Latest SOLE flash

20.09.2016:
Klarheit dank Genexpressionsanalyse Interview mit Prof. Dr. Stefan Aebi

All News

 
  Print